In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France

OBJECTIVES: Over recent years, France has experienced an increase of infections caused by carbapenem-resistant Gram-negative (GN) pathogens. Cefiderocol is approved in Europe for the treatment of aerobic GN infections in adults with limited treatment options. This study evaluated the in vitro activi...

Descripción completa

Detalles Bibliográficos
Autores principales: Naas, Thierry, Lina, Gerard, Santerre Henriksen, Anne, Longshaw, Christopher, Jehl, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251251/
https://www.ncbi.nlm.nih.gov/pubmed/34223140
http://dx.doi.org/10.1093/jacamr/dlab081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251251/
https://www.ncbi.nlm.nih.gov/pubmed/34223140
http://dx.doi.org/10.1093/jacamr/dlab081

Ejemplares similares